Mohammad-Reza Zarrindast Selected Research

Mohammad-Reza Zarrindast Research Topics

Disease

56	Amnesia (Dissociative Amnesia) 06/2021 - 08/2004
17	Pain (Aches) 05/2023 - 01/2006
17	Sleep Deprivation 01/2023 - 01/2016
16	Memory Disorders (Memory Loss) 12/2021 - 03/2014
7	Substance-Related Disorders (Drug Abuse) 06/2023 - 01/2014
7	Cholestasis 06/2023 - 06/2013
6	Opioid-Related Disorders (Opiate Addiction) 07/2015 - 07/2009
5	Morphine Dependence 07/2023 - 09/2002
5	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 04/2014
5	Cognitive Dysfunction 04/2022 - 11/2013
4	Inflammation (Inflammations) 02/2024 - 12/2020
4	Hyperalgesia 05/2023 - 05/2003
4	Mental Disorders (Mental Disorder) 01/2022 - 01/2019
3	Nervous System Diseases (Neurological Disorders) 01/2023 - 01/2019
3	Mood Disorders (Mood Disorder) 01/2022 - 09/2015
3	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2012
3	Hypothermia 06/2013 - 09/2002
2	Body Weight (Weight, Body) 02/2024 - 01/2019
2	Neuroinflammatory Diseases 02/2023 - 01/2022
2	Stroke (Strokes) 04/2022 - 01/2020
2	Multiple Sclerosis 04/2022 - 02/2020
2	Anxiety Disorders (Anxiety Disorder) 01/2022 - 01/2009
2	Neuralgia (Stump Neuralgia) 01/2021 - 12/2018
2	Hepatic Encephalopathy 12/2020 - 10/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	Neoplasms (Cancer) 07/2020 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 10/2018

Drug/Important Bio-Agent (IBA)

41	Morphine (MS Contin)FDA LinkGeneric 07/2023 - 05/2002
14	Opioid Analgesics (Opioids)IBA 11/2022 - 05/2002
13	Naloxone (Narcan)FDA LinkGeneric 11/2022 - 05/2002
13	Sulpiride (neogama)IBA 12/2021 - 08/2004
11	SCH 23390IBA 09/2019 - 08/2004
9	CannabinoidsIBA 01/2023 - 01/2015
8	Nicotine FDA Link 01/2019 - 05/2002
7	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 09/2002
7	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2023 - 03/2013
7	Anti-Anxiety Agents (Anxiolytics)IBA 11/2022 - 08/2013
7	MuscimolIBA 01/2020 - 01/2006
6	AntioxidantsIBA 02/2023 - 01/2020
6	Therapeutic UsesIBA 12/2022 - 02/2020
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017 - 05/2010
6	N-Methylaspartate (NMDA)IBA 10/2016 - 12/2008
5	Opioid Receptors (Opioid Receptor)IBA 06/2023 - 01/2018
5	Tramadol (K315)FDA LinkGeneric 06/2023 - 01/2019
5	BicucullineIBA 05/2023 - 01/2006
5	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2018
5	RS 67333IBA 06/2021 - 03/2014
5	harman (harmane)IBA 09/2019 - 11/2013
5	Messenger RNA (mRNA)IBA 01/2018 - 07/2009
5	Glutamic Acid (Glutamate)FDA Link 01/2017 - 06/2006
5	LithiumIBA 10/2016 - 11/2006
4	AM 251 (AM251)IBA 01/2023 - 03/2013
4	Streptozocin (Streptozotocin)FDA Link 12/2022 - 11/2013
4	salicylhydroxamic acid (SHAM)IBA 11/2022 - 06/2013
4	Arginine (L-Arginine)FDA Link 12/2021 - 06/2006
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2021 - 06/2006
4	Scopolamine (Hyoscine)FDA Link 10/2020 - 05/2010
4	NeuroaidIBA 06/2020 - 01/2019
4	Clonidine (ST 155)FDA LinkGeneric 01/2020 - 07/2003
4	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 09/2019 - 08/2004
4	Dopamine Receptors (Dopamine Receptor)IBA 01/2019 - 08/2005
4	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2014 - 07/2009
3	GABA-A Receptors (GABA(A) Receptor)IBA 04/2024 - 01/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2024 - 01/2019
3	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 11/2013
3	QuinpiroleIBA 12/2021 - 08/2004
3	Neuroprotective AgentsIBA 01/2021 - 12/2018
3	Imipramine (Janimine)FDA LinkGeneric 01/2021 - 07/2003
3	Yohimbine (Yocon)IBA 01/2020 - 07/2003
3	5-HT4 Serotonin ReceptorsIBA 01/2020 - 03/2014
3	Ketamine FDA LinkGeneric 11/2019 - 06/2016
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2019 - 09/2015
3	Dopamine AntagonistsIBA 01/2019 - 08/2013
3	azasetronIBA 09/2017 - 03/2014
3	Dizocilpine Maleate (Dizocilpine)IBA 04/2016 - 06/2006
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016 - 07/2003
3	Ethanol (Ethyl Alcohol)IBA 03/2013 - 12/2008
3	MecamylamineIBA 07/2008 - 05/2002
2	Histamine (Histamine Dihydrochloride)FDA Link 05/2023 - 07/2006
2	Citalopram FDA LinkGeneric 12/2022 - 01/2022
2	OrexinsIBA 12/2022 - 01/2022
2	HarmalineIBA 10/2022 - 10/2014
2	EndocannabinoidsIBA 10/2022 - 01/2006
2	Thimerosal (Thiomersal)IBA 06/2022 - 05/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 12/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 06/2006
2	Oxidopamine (6 Hydroxydopamine)IBA 12/2021 - 12/2021
2	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 12/2021 - 11/2019
2	Cytidine Diphosphate Choline (Citicoline)IBA 01/2021 - 10/2018
2	Amyloid (Amyloid Fibrils)IBA 12/2020 - 01/2019
2	NeuropeptidesIBA 06/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 04/2008

Therapy/Procedure

11	Injections 09/2019 - 08/2004
5	Analgesia 01/2023 - 09/2017
5	Ligation 11/2022 - 06/2013
4	Therapeutics 07/2020 - 07/2009
3	Transcranial Direct Current Stimulation 01/2019 - 11/2017
2	Intraperitoneal Injections 05/2023 - 07/2003
2	Cognitive Training 04/2022 - 01/2020